Key Metrics
Journal Specifications
- PublisherSPRINGER
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1987
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Cardiovascular Drugs and Therapy been publishing? 
The Cardiovascular Drugs and Therapy has been publishing since 1987 till date.
How frequently is the Cardiovascular Drugs and Therapy published? 
Cardiovascular Drugs and Therapy is published Bi-monthly.
Who is the publisher of Cardiovascular Drugs and Therapy? 
The publisher of Cardiovascular Drugs and Therapy is SPRINGER.
How can I view the journal metrics of Cardiovascular Drugs and Therapy on editage? 
For the Cardiovascular Drugs and Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Cardiovascular Drugs and Therapy? 
The eISSN number is 1573-7241 and pISSN number is 0920-3206 for Cardiovascular Drugs and Therapy.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Aspirin, Myocardial infarction, Heart disease, Atrial fibrillation, Matrix metalloproteinase, Type 2 diabetes, Anticoagulant, Left ventricular hypertrophy, Low-density lipoprotein, Atherosclerotic cardiovascular disease, Heart failure, Warfarin, Percutaneous coronary intervention, Clopidogrel, Naltrexone, Hyperoxia, Coronary heart disease, Confidence interval, Oxidative stress, Clinical trial.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.